Nestlé says national nutrition policy should also consider food industry concerns – ABS-CBN
Nestlé says national nutrition policy should also consider food industry concerns ABS-CBNBeverage industry urges DoF to review tax hike…
GLP-1s not a ‘lifestyle product’ – The Star
GLP-1s not a ‘lifestyle product’ The StarBeware the dangers of weight-loss medication The StarCentre says it has directed drug regulators…
Daily tomatoes lowered a key marker of liver fat in MASLD trial
A six-week tomato-rich diet outperformed a tomato-free diet on an important marker of hepatic steatosis, pointing to a…
Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ Comments
The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…
Loving your body in a world where weight stigma helps sell GLP-1 drugs
Whether you’re living in a body that’s large or small, the rise of GLP-1 advertising and its use…
Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ Comments
The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…
TGA issues warning over GLP-1-based drugs’ potential to cause rare eye disorder
The medicines regulator has issued a new safety warning for GLP-1-based drugs, like Ozempic, which could potentially cause…
From 98 Kg To 78 Kg: Woman Shares The Diet Plan That Helped Her Lose 20 Kg
There is a fine line between body shaming and expressing concern about someone’s obesity. Adity Bhargav’s story highlights…
Lilly to file for next-gen obesity drug approval in early 2027
Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
An enzyme might help fight against your body’s aging
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism
Dual agonism of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors (GLP-1R and GIPR, respectively), in the…
New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook
Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…